Compound Profile: Aromasin Beligas
Aromasin Beligas exemestane is a steroidal aromatase inhibitor extensively studied for its mechanism of irreversibly binding to the aromatase enzyme (CYP19A1). This compound demonstrates potent inhibition of estrogen biosynthesis in preclinical models, making it valuable for researchers investigating hormonal pathways and endocrine disruption studies. Scientists at Stroid UK Shop utilise this compound to examine aromatase activity modulation in controlled laboratory environments.
Laboratory Applications
Research teams analyse exemestane for its distinctive suicide inhibition mechanism, where the compound forms irreversible covalent bonds with the aromatase active site. This characteristic differentiates it from reversible inhibitors, providing researchers unique insights into enzyme kinetics and hormonal regulation. Studies examine its effects on estrogen-dependent pathways, comparing its activity profile against compounds found in our aromatase inhibitor collection. Investigators also research its potential interactions with other research chemicals including selective androgen receptor modulators and synthetic peptides in multi-compound investigations.
Compound Specifications
| Parameter | Specification |
|---|---|
| CAS Number | 107868-30-4 |
| Molecular Formula | C₂₀H₂₄O₂ |
| Molecular Weight | 296.40 g/mol |
| Chemical Class | Steroidal aromatase inhibitor |
| Storage Requirements | Room temperature, dry environment |
| Solubility | DMSO, ethanol (verify protocols) |
Research Compliance
This exemestane research chemical is manufactured exclusively for in-vitro laboratory investigations and analytical testing purposes. Research institutions must ensure proper handling protocols and regulatory compliance when conducting studies with this aromatase inhibitor. All experimental work should follow established laboratory safety guidelines and institutional research ethics approval.
